Dynamics of Cortical Degeneration Over a Decade in Huntington's Disease (vol 89, pg 807, 2021)

被引：0
|
作者：
Johnson, Eileanoir B.
Ziegler, Gabriel
Penny, William
Rees, Geraint
Tabrizi, Sarah J.
Scahill, Rachael I.
Gregory, Sarah
机构：
来源：
BIOLOGICAL PSYCHIATRY | 2021年 / 90卷 / 04期
关键词：
D O I：
10.1016/j.biopsych.2021.05.020
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：275 / 275
页数：1
相关论文
共 50 条
  • [1] Dynamics of Cortical Degeneration Over a Decade in Huntington's Disease (vol 89, pg 807, 2021)
    Johnson
    BIOLOGICAL PSYCHIATRY, 2021, 90 (07) : 505 - 505
  • [2] Dynamics of Cortical Degeneration Over a Decade in Huntington's Disease
    Johnson, Eileanoir B.
    Ziegler, Gabriel
    Penny, William
    Rees, Geraint
    Tabrizi, Sarah J.
    Scahill, Rachael, I
    Gregory, Sarah
    BIOLOGICAL PSYCHIATRY, 2021, 89 (08) : 807 - 816
  • [3] One Decade Ago, One Decade Ahead in Huntington's Disease (vol 34, pg 1434, 2019)
    Wild, E. J.
    Tabrizi, S. J.
    MOVEMENT DISORDERS, 2020, 35 (01) : 199 - 199
  • [4] Cortical peptide changes in Huntington's disease may be independent of striatal degeneration
    Mazurek, MF
    Garside, S
    Beal, MF
    ANNALS OF NEUROLOGY, 1997, 41 (04) : 540 - 547
  • [5] Cortical Network Dynamics Is Altered in Mouse Models of Huntington's Disease
    Donzis, Elissa J.
    Maria Estrada-Sanchez, Ana
    Indersmitten, Tim
    Oikonomou, Katerina
    Tran, Conny H.
    Wang, Catherine
    Latifi, Shahrzad
    Golshani, Peyman
    Cepeda, Carlos
    Levine, Michael S.
    CEREBRAL CORTEX, 2020, 30 (04) : 2372 - 2388
  • [6] A case of Alport's syndrome and retinal degeneration (vol 21, pg 89, 2001)
    Tsilou
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2001, 21 (04): : 392 - 392
  • [7] Neuroprotection in Huntington's disease (vol 26, pg 223, 2003)
    Lahousen, T
    Bonelli, RM
    CLINICAL NEUROPHARMACOLOGY, 2003, 26 (06) : 330 - 330
  • [8] Dopamine and Huntington's disease (vol 15, pg 445, 2015)
    Schwab, L. C.
    Garas, S. N.
    Drouin-Ouellet, J.
    Mason, S. L.
    Stott, S. R.
    Barker, R. A.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (11) : 1367 - 1367
  • [9] Reversible Huntington's disease? (vol 352, pg 1520, 1998)
    Bonelli, RM
    Költringer, P
    Kenner, L
    Reisecker, F
    LANCET, 2003, 362 (9388): : 1000 - 1000
  • [10] Questions swirl around failures of disease-modifying Huntington's drugs (vol 39, pg 650, 2021)
    Sheridan, Cormac
    NATURE BIOTECHNOLOGY, 2021, 39 (08) : 1017 - 1017
12345